VEBLOCEMA sol inj 120 mg/ml stylo pré
7680678880017
CH-67888
L04AB02
07.15.0.
Reimbursement limitations:
VEBLOCEMA
Le traitement par VEBLOCEMA exige une garantie préalable de prise en charge des coûts par …
1 / 3
google
Details
- Product number
- 6788801
- CPT
- -
- Packaging group
- 1
- Unit
- Injektor(en), vorgefüllt/Pen
- Composition
- infliximabum 120 mg, acidum aceticum, natrii acetas trihydricus, sorbitolum 45 mg, polysorbatum 80, aqua ad iniectabile, q.s. ad solutionem pro 1 ml corresp. natrium 0.16 mg.
Articles (1)
Veblocema 120 mg, solution injectable en stylo prérempli
Lösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
120.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
45.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.16 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 592.00
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/07/2022
Authorization holder
IQONE HEALTHCARE SWITZERLAND
1290 Versoix
Authorization information
- Swissmedic authorization number
- 67888
- Drug name
- Veblocema, solution injectable en stylo prérempli
- Galenic form
- INLFP
- ATC Code
- L04AB02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 29/06/2021
- Authorization expiration date
- 28/06/2026
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- VEBLOCEMA sol inj 120 mg/ml stylo pré
- Description (DE)
- VEBLOCEMA Inj Lös 120 mg/ml Fertpen
- Market launch
- 29/06/2021
- Narcotic (BTM)
- No